vs
Side-by-side financial comparison of AUBURN NATIONAL BANCORPORATION, INC (AUBN) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.
Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $8.5M, roughly 1.1× AUBURN NATIONAL BANCORPORATION, INC). AUBURN NATIONAL BANCORPORATION, INC runs the higher net margin — 19.7% vs -234.3%, a 253.9% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 8.4%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 5.9%).
Auburn Bank is an American community bank providing services in the East of Alabama as a state registered bank. The Bank offers financial products and services including checking, savings, and lending. The bank is a member of the Federal Home Loan Bank of Atlanta. Its operation is regulated by the Alabama Superintendent of Banks.
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
AUBN vs FHTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.5M | $9.2M |
| Net Profit | $1.7M | $-21.7M |
| Gross Margin | — | — |
| Operating Margin | 25.1% | -258.2% |
| Net Margin | 19.7% | -234.3% |
| Revenue YoY | 8.4% | 223.8% |
| Net Profit YoY | 6.7% | -11.1% |
| EPS (diluted) | — | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.5M | $9.2M | ||
| Q3 25 | $8.4M | $8.2M | ||
| Q2 25 | $8.1M | $7.6M | ||
| Q1 25 | $7.8M | $6.0M | ||
| Q4 24 | $7.8M | $2.9M | ||
| Q3 24 | $7.6M | $7.8M | ||
| Q2 24 | $7.6M | $6.9M | ||
| Q1 24 | $7.5M | $5.0M |
| Q4 25 | $1.7M | $-21.7M | ||
| Q3 25 | $2.2M | $-15.8M | ||
| Q2 25 | $1.8M | $-17.9M | ||
| Q1 25 | $1.5M | $-18.8M | ||
| Q4 24 | $1.6M | $-19.5M | ||
| Q3 24 | $1.7M | $-19.1M | ||
| Q2 24 | $1.7M | $-23.0M | ||
| Q1 24 | $1.4M | $-25.0M |
| Q4 25 | 25.1% | -258.2% | ||
| Q3 25 | 33.9% | -226.9% | ||
| Q2 25 | 28.5% | -279.2% | ||
| Q1 25 | 24.7% | -385.0% | ||
| Q4 24 | 30.6% | -840.5% | ||
| Q3 24 | 29.6% | -305.5% | ||
| Q2 24 | 29.0% | -386.6% | ||
| Q1 24 | 20.3% | -558.3% |
| Q4 25 | 19.7% | -234.3% | ||
| Q3 25 | 26.5% | -194.4% | ||
| Q2 25 | 22.5% | -237.3% | ||
| Q1 25 | 19.6% | -316.4% | ||
| Q4 24 | 20.0% | -682.9% | ||
| Q3 24 | 22.7% | -244.9% | ||
| Q2 24 | 22.8% | -333.6% | ||
| Q1 24 | 18.2% | -495.4% |
| Q4 25 | — | $-0.35 | ||
| Q3 25 | $0.64 | $-0.25 | ||
| Q2 25 | — | $-0.28 | ||
| Q1 25 | — | $-0.30 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | $0.50 | $-0.31 | ||
| Q2 24 | — | $-0.45 | ||
| Q1 24 | — | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $80.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $92.1M | $-108.5M |
| Total Assets | $1.0B | $198.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $80.9M | ||
| Q3 25 | — | $89.3M | ||
| Q2 25 | — | $72.6M | ||
| Q1 25 | — | $61.0M | ||
| Q4 24 | — | $55.5M | ||
| Q3 24 | — | $57.7M | ||
| Q2 24 | — | $138.9M | ||
| Q1 24 | — | $79.3M |
| Q4 25 | $92.1M | $-108.5M | ||
| Q3 25 | $89.6M | $-89.7M | ||
| Q2 25 | $86.1M | $-76.7M | ||
| Q1 25 | $83.1M | $-61.7M | ||
| Q4 24 | $78.3M | $-45.5M | ||
| Q3 24 | $84.3M | $-28.3M | ||
| Q2 24 | $75.2M | $-14.3M | ||
| Q1 24 | $74.5M | $-97.5M |
| Q4 25 | $1.0B | $198.1M | ||
| Q3 25 | $1.0B | $205.0M | ||
| Q2 25 | $1.0B | $226.2M | ||
| Q1 25 | $996.8M | $258.7M | ||
| Q4 24 | $977.3M | $284.0M | ||
| Q3 24 | $990.1M | $308.4M | ||
| Q2 24 | $1.0B | $328.6M | ||
| Q1 24 | $979.0M | $255.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | $-22.3M |
| Free Cash FlowOCF − Capex | $10.9M | — |
| FCF MarginFCF / Revenue | 128.3% | — |
| Capex IntensityCapex / Revenue | 17.5% | 0.0% |
| Cash ConversionOCF / Net Profit | 7.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | $-22.3M | ||
| Q3 25 | $4.1M | $-18.9M | ||
| Q2 25 | $2.1M | $-21.0M | ||
| Q1 25 | $2.6M | $-24.0M | ||
| Q4 24 | $10.8M | $-24.5M | ||
| Q3 24 | $1.9M | $-21.0M | ||
| Q2 24 | $3.1M | $-25.5M | ||
| Q1 24 | $3.1M | $-29.3M |
| Q4 25 | $10.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-21.0M | ||
| Q1 25 | — | $-24.0M | ||
| Q4 24 | $8.7M | $-25.0M | ||
| Q3 24 | — | $-21.3M | ||
| Q2 24 | — | $-25.6M | ||
| Q1 24 | — | $-29.4M |
| Q4 25 | 128.3% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -278.2% | ||
| Q1 25 | — | -403.2% | ||
| Q4 24 | 111.6% | -875.3% | ||
| Q3 24 | — | -273.0% | ||
| Q2 24 | — | -371.0% | ||
| Q1 24 | — | -583.1% |
| Q4 25 | 17.5% | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | 26.7% | 16.8% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 2.0% |
| Q4 25 | 7.42× | — | ||
| Q3 25 | 1.83× | — | ||
| Q2 25 | 1.17× | — | ||
| Q1 25 | 1.72× | — | ||
| Q4 24 | 6.93× | — | ||
| Q3 24 | 1.08× | — | ||
| Q2 24 | 1.76× | — | ||
| Q1 24 | 2.25× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
